Mukanov , K., Mukantayev , K. and Tarlykov , P. 2018. GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER. Eurasian Journal of Applied Biotechnology. 1 (Jan. 2018). DOI:https://doi.org/10.11134/btp.1.2018.4.